SCHEMBL4455979

SCHEMBL4455979

CCC(C)(C)C1=CC(=CC(=O)O)C=C(C(C)(C)CC)C1=O

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.30
GPR55 Q9Y2T6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19334865 0.76
SCHEMBL2475739 0.73 KMT2A (0.41)
SCHEMBL11421705 0.73 ATM (0.36)
SCHEMBL4523897 0.72
SCHEMBL17969770 0.71
SCHEMBL11678515 0.69 CYP1A2 (0.42)
SCHEMBL8675243 0.68 ATM (0.39) POLBGPR55
SCHEMBL4456724 0.67 ATM (0.41) POLBGPR55
SCHEMBL8611923 0.66 ATM (0.38)
SCHEMBL8144898 0.66 ATM (0.43) POLBGPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7473795-B2 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors UNIROYAL CHEMICAL COMPANY, INC. (US) 2009-01-06 US claimed
US-20060155140-A1 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors UNIROYAL CHEMICAL COMPANY, INC A CORPORATION OF THE STATE OF DELAWARE 2006-07-13 US claimed
US-7045647-B2 Blends of quinone alkide and nitroxyl compounds and polymerization inhibitors UNIROYAL CHEMICAL COMPANY, INC. (US) 2006-05-16 US claimed
EP-1379584-B1 FLAME RETARDANT COMPOSITIONS CIBA SC HOLDING AG (CH) 2005-08-24 EP claimed
US-20040097619-A1 Flame retardant compositions CIBA SPECIALTY CHEMICALS CORP. 2004-05-20 US claimed
US-20040010159-A1 Blends of quinone alkide and nitroxyl compounds and polymerization inhibitors ADDIVANT USA, LLC 2004-01-15 US claimed
EP-1379584-A1 FLAME RETARDANT COMPOSITIONS Ciba Specialty Chemicals Holding Inc. (CH) 2004-01-14 EP claimed
EP-1332196-A1 BLENDS OF QUINONE ALKIDE AND NITROXYL COMPOUNDS AS POLYMERIZATION INHIBITORS Uniroyal Chemical Company, Inc. (US) 2003-08-06 EP claimed
WO-2002074847-A1 FLAME RETARDANT COMPOSITIONS CIBA SPECIALITY CHEMICALS HOLDING INC. (CH) 2002-09-26 WO claimed
WO-2002033026-A1 BLENDS OF QUINONE ALKIDE AND NITROXYL COMPOUNDS AS POLYMERIZATION INHIBITORS UNIROYAL CHEMICAL COMPANY, INC. (US) 2002-04-25 WO claimed
US-5670692-A 7-substituted quinone methides as inhibitors for unsaturated monomers CIBA-GEIGY CORPORATION (US) 1997-09-23 US claimed
US-5583247-A PREMATURE POLYMERIZATION STABILIZERS CIBA-GEIGY CORPORATION (US) 1996-12-10 US claimed
US-7473795-B2 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors UNIROYAL CHEMICAL COMPANY, INC. (US) 2009-01-06 US disclosed
US-7470734-B2 Flame retardant compositions CIBA SPECIALTY CHEMICALS CORPORATION (US) 2008-12-30 US disclosed
US-7084196-B2 Flame retardant compositions CIBA SPECIALTY CHEMICALS CORPORATION (US) 2006-08-01 US disclosed
US-20060155140-A1 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors UNIROYAL CHEMICAL COMPANY, INC A CORPORATION OF THE STATE OF DELAWARE 2006-07-13 US disclosed
US-5750765-A 7-substituted quinone methides as inhibitors for unsaturated monomers CIBA SPECIALTY CHEMICALS CORPORATION (US) 1998-05-12 US disclosed
US-5670692-A 7-substituted quinone methides as inhibitors for unsaturated monomers CIBA-GEIGY CORPORATION (US) 1997-09-23 US disclosed
US-5583247-A PREMATURE POLYMERIZATION STABILIZERS CIBA-GEIGY CORPORATION (US) 1996-12-10 US disclosed
EP-0737659-A1 7-Substituted quinone methides as inhibitors for unsaturated monomers CIBA-GEIGY AG (CH) 1996-10-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060155140-A1 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors SQOR, NQO1, NQO2 POLB 89/4885GPR55 4090/4885
US-20040010159-A1 Blends of quinone alkide and nitroxyl compounds and polymerization inhibitors SQOR, NQO1, NQO2 POLB 85/4885GPR55 4171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.